Recent News

• 06.10.2026 - Daniel Baker, M.D.
• 06.10.2026 - Sumita Ray, J.D.
• 06.02.2026 - Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution
• 06.02.2026 - Viola Meehan
• 06.02.2026 - Daniel Camardo
• 05.21.2026 - Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference
• 05.14.2026 - Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments

Recent Filings

• 06.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.08.2026 - 3 Initial statement of beneficial ownership of securities
• 06.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 06.03.2026 - S-3 Registration statement under Securities Act of 1933
• 06.03.2026 - 8-K Current report
• 06.02.2026 - 3 Initial statement of beneficial ownership of securities
• 06.02.2026 - 8-K Current report
• 06.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.21.2026 - DEF 14A Other definitive proxy statements